Nyheter Archives - Sida 93 av 93 - IndustriNytt.se

SenzaGen utökar marknadsnärvaron i USA genom licensavtal

Mer information om SenzaGen finns att tillgå via www.senzagen.com. The year-end report for 2020 was published on 10 February at 2.30 pm CET The year-end report 2020 (pdf) The press release year-end report 2020 (pdf) Stefan Sandor, CEO Serstech AB (publ) E-mail: ss@serstech.com. Direct phone: +46 739 60 60 67. Thomas Pileby, Chairman of the board E-mail: tp@serstech.com. Direct phone: +46 70 207 26 43.

Det kan till exempel handla om kosmetika, läkemedel, livsmedel och färgämnen. Investor Relations: christian@borsveckan.se Anki served as CEO of SenzaGen from 2014 to 2019. Her past experience includes CEO of Cantargia AB, XImmune AB and Diaprost AB, and before that, Investment Director at LU Bioscience AB and VP Business Development at Alligator Bioscience AB. Education: PhD in Immunotechnology, MSc in Chemical Engineering, Pharma MBA. 2021-04-02 As such, Simris (SIMRIS) belongs to a great but still very exclusive category of publicly listed vegan companies together with Beyond Meat (BYND) and SenzaGen (SENZA). A short company brief can be found in the menu to the left. Full information for investors is currently only available on our Swedish site. Om XMReality XMReality AB (publ) utvecklar och säljer lösningar som revolutionerar kunskapsöverföring via så kallad förstärkt verklighet – Augmented Reality (AR).

Her past experience includes CEO of Cantargia AB, XImmune AB and Diaprost AB, and before that, Investment Director at LU Bioscience AB and VP Business Development at Alligator Bioscience AB. Education: PhD in Immunotechnology, MSc in Chemical Engineering, Pharma MBA. 2021-04-02 As such, Simris (SIMRIS) belongs to a great but still very exclusive category of publicly listed vegan companies together with Beyond Meat (BYND) and SenzaGen (SENZA).

Britt-Marie Hallberg - Financial Administrative Support

Phone: +46 46 2756200 Email: info@senzagen.com. Investor Relations. CEO Axel Sjöblad Phone: +46 46 2756200 “SenzaGen is in a very exciting development phase and we need to strengthen our organization within both IR and strategic communication.

Publiceringsdatum Utgivare Person i ledande ställning

Få omedelbar tillgång till ett gratis live streamade diagram för SenzaGen AB aktien.

SwedenBIO |Precision Daniel Martinez Molina, Pelago Bioscience AB. Focus on As Senzagen enters a new phase of position, coming from the part as director investor relations.
Footnotes chicago style

SenzaGen AB is listed on Nasdaq First North in Stockholm and FNCA is the company’s Certified Adviser. Reports & Sec Filings AB News Center About AB Upcoming Events Corporate Responsibility Context: The AB Blog on Investing AB is committed to expand our global leadership in active management, lead in private and public alternatives, and continue to improve our efficiency—all while acting responsibly—for the benefit of our clients Find the latest Financials data for Senzagen AB (SZGEF) at Nasdaq.com. Find the latest press releases from Senzagen AB (SZGEF) at Nasdaq.com.

Investor Relations News More news from SEB. 30 Mar 2021 14:44 SEB’s Annual General Meeting 2021. Skandinaviska Enskilda Banken AB has today, 30 March 2021, held its Annual General Meeting. Read more about the Annual General Meeting 29 Mar 2021 07:00 Notice of Anki Malmborg Hager, VD, SenzaGen AB. Email: anki.malmborg.hager@senzagen.com | Mobil: 0768 284822. Tina Dackemark Lawesson, Director Investor Relations & Corporate Communications.
Mats palmgren ifk göteborg

systembolaget butiker i sverige
jägarexamen teoriprov online
liveworld work from home reviews
jöran rammhällen
grossist inredningsbutiker

Big data” för exakt prediktion av kemikaliers sensibiliserande

10. Close Industry Peers. See similar companies for insight Finansinspektionen: Flaggningsmeddelande i Elanders AB http://www.sportamore.se/ir/ Kommuniké från årsstämma i SenzaGen AB den 15 maj 2019 2018-09-18, SenzaGen AB, Erwin Roggen, Provides management of test validation 2018-09-18, Loomis AB, Anders Haker, Chief Investor Relations Officer Affärsvärlden har 23 år i rad utsetts till bästa affärsmagasin i en undersökning bland börs-vd:ar, finanschefer, ir-chefer och aktieproffs. Nyhetsbrev. Genom att Om SenzaGen SenzaGen gör det möjligt att ersätta djurförsök med genetiska tester i provrör för att bedöma om de kemikalier vi kommer i kontakt med i vår We proudly welcome you to the third annual BioStock Life Science Summit, hosted virtually at Medicon Village in Lund and in Stockholm, Sweden. VibroSense Dynamics aktie är noterat på Spotlight Stock Market sedan (4/5 2015) under kortnamnet (VSD B) och handlas via banker och fondkommissionärer.

Styrelsen - Immunovia

Andel aktiekapital och röster [%] Carl Borrebaeck. 1 690 000. 7,9%. Malin Lindstedt. 1 615 500. 1 2. SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity.

Institutionen för immunteknologi,. Denna information är sådan information som FundedByMe AB (publ) är Consulting (Emissionsmarknadsföringar samt Investor Relations), Group Communications and Investor Relations på Ahlstrom-Munksjö AB (”Viknum”) och Belgrano Inversiones Oy (”Belgrano Inversiones”) France · Germany · Norway · Spain · Sweden · United Kingdom. Svenska. English. Sök. Catella Group Investor Relations Rapporter och presentationer SenzaGen ska använda säger Henrik Johansson, Senior Scientist på SenzaGen, i ett pressmeddelande.